Published online before print October 4, 2004, doi: 10.1161/01.CIR.0000144304.91010.F0
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:2077-2082.)
© 2004 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
KATP Channel Activation Induces Ischemic Preconditioning of the Endothelium in Humans In Vivo
From the Centre for Clinical Pharmacology (M.W.B., R.J.M.), University College London, London, United Kingdom; Division of Cardiovascular Medicine (R.K.K.), Addenbrookes Hospital, Cambridge, United Kingdom; and Critical Care Group (M.W.B., M.J.P.), Portex Unit, Institute of Child Health, London, United Kingdom.
Correspondence to M.W. Broadhead, Centre for Clinical Pharmacology, BHF Laboratories, The Rayne Building, 5 University St, London WC1E 6JJ, England. E-mail M.Broadhead{at}ich.ucl.ac.uk
Received January 15, 2004; de novo received May 20, 2004; accepted June 22, 2004.
Background— Endothelial dysfunction contributes to ischemia-reperfusion injury (IRI) and is reduced by ischemic preconditioning (IPC). IPC may involve activation of ATP-sensitive potassium channels (KATP). We determined whether modulation of KATP channels occurs in endothelial IPC in humans.
Methods and Results— IRI of the forearm was induced by inflating a blood pressure cuff to 200 mm Hg for 20 minutes in healthy volunteers. KATP activation was modulated by intra-arterial glibenclamide (blocker) and diazoxide (opener). Endothelial function (response to intra-arterial acetylcholine) was assessed with forearm plethysmography before and after (1) 15-minute reperfusion, (2) IRI preceded by IPC (3 five-minute periods of ischemia), (3) IRI preceded by IPC with glibenclamide, (4) IPC followed by glibenclamide before IRI, (5) IRI preceded by diazoxide, and (6) IRI preceded by coinfusion of glibenclamide with diazoxide. IRI caused endothelial dysfunction (P=0.002), which IPC prevented (P=0.40). Glibenclamide abolished IPC when given contemporaneously with (P=0.003) or during IRI (P=0.0005). Diazoxide prevented endothelial dysfunction after IRI (P=0.68) but not when coinfused with glibenclamide.
Conclusion— Glibenclamide abolishes and diazoxide mimics endothelial IPC in humans. The time course of the effect of glibenclamide suggests involvement of KATP channels as effectors of endothelial IPC in vivo. These data may have implications for understanding the therapeutic role of agents that modulate KATP channel function.
Key Words: ischemia • reperfusion • potassium channels • ischemic preconditioning
This article has been cited by other articles:
 |
|
 |
|
  A. R. Assad, J. M. A. Delou, L. M. Fonseca, N. R. Villela, J. H. M. Nascimento, N. Vercosa, A. G. Lopes, and M. A.M. Capella The Role of KATP Channels on Propofol Preconditioning in a Cellular Model of Renal Ischemia-Reperfusion Anesth. Analg., November 1, 2009; 109(5): 1486 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szabo, T. Radovits, G. Veres, N. Krieger, S. Loganathan, P. Sandner, and M. Karck Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 657 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Hoole, P. M. Heck, P. A. White, S. N. Khan, M. O'Sullivan, S. C. Clarke, and D. P. Dutka Remote Ischemic Preconditioning Stimulus Does Not Reduce Microvascular Resistance or Improve Myocardial Blood Flow in Patients Undergoing Elective Percutaneous Coronary Intervention Angiology, August 1, 2009; 60(4): 403 - 411. [Abstract] [PDF]
|
|
|
|
|
|
E. Lucchinetti, J. Wacker, C. Maurer, M. Keel, L. Harter, K. Zaugg, and M. Zaugg Helium Breathing Provides Modest Antiinflammatory, but No Endothelial Protection Against Ischemia-Reperfusion Injury in Humans In Vivo Anesth. Analg., July 1, 2009; 109(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Hoole, S. N. Khan, P. A. White, P. M. Heck, R. K. Kharbanda, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al. Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans Eur J Heart Fail, May 1, 2009; 11(5): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Hoole, P. M. Heck, L. Sharples, S. N. Khan, R. Duehmke, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial Circulation, February 17, 2009; 119(6): 820 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-X. Zhang, X.-M. Lu, S. Kimura, and A. Nishiyama Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation Cardiovasc Res, November 1, 2007; 76(2): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Loukogeorgakis, R. Williams, A. T. Panagiotidou, S. K. Kolvekar, A. Donald, T. J. Cole, D. M. Yellon, J. E. Deanfield, and R. J. MacAllister Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel Dependent Mechanism Circulation, September 18, 2007; 116(12): 1386 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mayahi, S. Heales, D. Owen, J. P. Casas, J. Harris, R. J. MacAllister, and A. D. Hingorani (6R)-5,6,7,8-Tetrahydro-L-Biopterin and Its Stereoisomer Prevent Ischemia Reperfusion Injury in Human Forearm Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1334 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Davidson and M. R. Duchen Endothelial Mitochondria: Contributing to Vascular Function and Disease Circ. Res., April 27, 2007; 100(8): 1128 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Gross Remote preconditioning and delayed cardioprotection in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1562 - R1563. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Gross Sildenafil and Endothelial Dysfunction in Humans Circulation, February 15, 2005; 111(6): 721 - 723. [Full Text] [PDF]
|
|